The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which is widely referred to as “COVID-19”, has been infecting more than 5.5 million over 144 countries. A vaccine is considered to be the most awaiting intervention and hundreds of global R&D institutions engaged in unprecedented speed to develop the vaccine. The availability of COVID-19 vaccines may not translate into its uptake. Although governments will provide the vaccines, their uptake is voluntary. Objective: This study was carried out to evaluate the level of acceptance of COVID-19 vaccine and it’s determinants among high risk groups for severe COVID-19 infection living in Mogadishu Somalia. Methods: The study was cross-sectional, descriptive analysis conducted to obtain reliable information about the acceptance of COVID-19 vaccine and it is determinants among high-risk groups living in Mogadishu, Somalia. The calculated sample size was 404 using Cochran’s formula = Z2p(1 − p)/d2 and addition of 5% non-respondent rate. According to PESS population estimate in 2020, there are 17 districts. We grouped them into 2 strata and through simple random sampling one district was selected from each strata. After randomly selecting the two districts, three sub districts were randomly selected from each and then every second house (1, 3, 5) in the main roads will be selected. If target population were not found in the second selected house, the next house will be taken until sample size is obtained. Results: 59.4% of respondents were willing to accept and take vaccination while 40.6% of them were not accepting the vaccination. Being afraid of the side effect was the most common reason for not accepting the vaccine Conclusion: More than one third of respondents (40.6%) were not willing to accept the vaccination, knowledge towards COVID-19 was strongly associated with acceptance level of COVID-19 vaccine. Recommendation: Multi-sector organized awareness campaigns involving FMH as well as local authorities and civil society to enhance level of knowledge of community towards COVID-19.
References
[1]
Chakraborty, C., Sharma, A.R., Sharma, G., Bhattacharya, M. and Lee, S.S. (2020) SARS-CoV-2 Causing Pneumonia-Associated Respiratory Disorder (COVID-19): Diagnostic and Proposed Therapeutic Options. European Review for Medical and Pharmacological Sciences, 24, 4016-4026.
[2]
Saha, R.P., Sharma, A.R., Singh, M.K., et al. (2020) Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives against COVID-19. Frontiers in Pharmacology, 11, 1258. https://doi.org/10.3389/fphar.2020.01258
[3]
Chakraborty, C., Sharma, A.R., Bhattacharya, M., Sharma, G. and Lee, S.S. (2020) The 2019 Novel Coronavirus Disease (COVID-19) Pandemic: A Zoonotic Prospective. Asian Pacific Journal of Tropical Medicine, 13, 242.
https://doi.org/10.4103/1995-7645.281613
[4]
Chakraborty, C., Sharma, A.R., Sharma, G., Bhattacharya, M., Saha, R.P. and Lee, S.-S. (2020) Extensive Partnership, Collaboration, and Teamwork Is Required to Stop the COVID-19 Outbreak. Archives of Medical Research, 51, 728-730.
https://doi.org/10.1016/j.arcmed.2020.05.021
[5]
Bhattacharya, M., Sharma, A.R., Patra, P., et al. (2020) Development of Epitope-Based Peptide Vaccine against Novel Coronavirus 2019 (SARS-COV-2): Immunoinformatics Approach. Journal of Medical Virology, 92, 618-631.
https://doi.org/10.1002/jmv.25736
[6]
Wu, S., Su, J., Yang, P., et al. (2018) Willingness to Accept a Future Influenza A (H7N9) Vaccine in Beijing, China. Vaccine, 36, 491-497.
https://doi.org/10.1016/j.vaccine.2017.12.008
[7]
Larson, H.J., Jarrett, C., Eckersberger, E., Smith, D.M.D. and Paterson, P. (2014) Understanding Vaccine Hesitancy around Vaccines and Vaccination from a Global Perspective: A Systematic Review of Published Literature, 2007-2012. Vaccine, 32, 2150-2159. https://doi.org/10.1016/j.vaccine.2014.01.081
[8]
Nzaji, M.K., Ngombe, L.K., Mwamba, G.N., et al. (2020) Acceptability of Vaccination against COVID-19 among Healthcare Workers in the Democratic Republic of the Congo. Pragmatic and Observational Research, 11, 103-109.
https://doi.org/10.2147/POR.S271096
[9]
Shaw, J., Stewart, T. anderson, K.B., et al. (2021) Assessment of US Health Care Personnel (HCP) Attitudes towards COVID-19 Vaccination in a Large University Health Care System. Clinical Infectious Diseases.
https://doi.org/10.1093/cid/ciab054
[10]
Ahmed, M.A.M., et al. (2021) COVID-19 Vaccine Acceptability and Adherence to Preventive Measures in Somalia: Results of an Online Survey.
https://doi.org/10.3390/vaccines9060543
[11]
Shekhar, R., Sheikh, A.B., Upadhyay, S., et al. (2021) COVID-19 Vaccine Acceptance among Health Care Workers in the United States. Vaccines, 9, 119.
https://doi.org/10.3390/vaccines9020119
[12]
Persad, G., Peek, M.E. and Emanuel, E.J. (2020) Fairly Prioritizing Groups for Access to COVID-19 Vaccines. JAMA, 324, 1601-1602.
https://doi.org/10.1001/jama.2020.18513
[13]
Dooling, K., McClung, N., Chamberland, M., Marin, M., Wallace, M., Bell, B.P., Lee, G.M., Talbot, H.K., Romero, J.R. and Oliver, S.E. (2020) The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine—United States, 2020. Morbidity and Mortality Weekly Report, 69, 1857. https://doi.org/10.15585/mmwr.mm6949e1
[14]
Dror, A.A., Eisenbach, N., Taiber, S., Morozov, N.G., Mizrachi, M., Zigron, A., Srouji, S. and Sela, E. (2020) Vaccine Hesitancy: The Next Challenge in the Fight against COVID-19. European Journal of Epidemiology, 35, 775-779.
https://doi.org/10.1007/s10654-020-00671-y
[15]
Hacquin, A.S., Altay, S., de Araujo, E., Chevallier, C. and Mercier, H. (2020) Sharp Rise in Vaccine Hesitancy in a Large and Representative Sample of the French Population: Reasons for Vaccine Hesitancy.
[16]
Latkin, C.A., Dayton, L., Yi, G., Colon, B. and Kong, X. (2021) Mask Usage, Social Distancing, Racial, and Gender Correlates of COVID-19 Vaccine Intentions among Adults in the US. PLoS ONE, 16, e0246970.
https://doi.org/10.1371/journal.pone.0246970
[17]
Murphy, J., Vallières, F., Bentall, R.P., Shevlin, M., McBride, O., Hartman, T.K., McKay, R., Bennett, K., Mason, L., Gibson-Miller, J., et al. (2021) Psychological Characteristics Associated with COVID-19 Vaccine Hesitancy and Resistance in Ireland and the United Kingdom. Nature Communications, 12, 29.
https://doi.org/10.1038/s41467-020-20226-9
[18]
Flanagan, K.L., Fink, A.L., Plebanski, M. and Klein, S.L. (2017) Sex and Gender Differences in the Outcomes of Vaccination over the Life Course. Annual Review of Cell and Developmental Biology, 33, 577-599.
https://doi.org/10.1146/annurev-cellbio-100616-060718
[19]
He, J. and He, L. (2018) Knowledge of HPV and Acceptability of HPV Vaccine among Women in Western China: A Cross-Sectional Survey. BMC Women’s Health, 18, 130. https://doi.org/10.1186/s12905-018-0619-8
[20]
Yeung, M.P., Lam, F.L. and Coker, R. (2016) Factors Associated with the Uptake of Seasonal Influenza Vaccination in Adults: A Systematic Review. Journal of Public Health, 38, 746-753. https://doi.org/10.1093/pubmed/fdv194
[21]
Jarrett, C., Wilson, R., O’Leary, M., Eckersberger, E. and Larson, H.J. (2015) Strategies for Addressing Vaccine Hesitancy—A Systematic Review. Vaccine, 33, 4180-4190. https://doi.org/10.1016/j.vaccine.2015.04.040
